Cargando…

Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues

[Image: see text] Lactimidomycin (LTM, 1) and iso-migrastatin (iso-MGS, 2) belong to the glutarimide-containing polyketide family of natural products. We previously cloned and characterized the mgs biosynthetic gene cluster from Streptomyces platensis NRRL 18993. The iso-MGS biosynthetic machinery f...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Jeong-Woo, Ma, Ming, Kwong, Thomas, Ju, Jianhua, Lim, Si-Kyu, Jiang, Hui, Lohman, Jeremy R., Yang, Chunying, Cleveland, John, Zazopoulos, Emmanuel, Farnet, Chris M., Shen, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270375/
https://www.ncbi.nlm.nih.gov/pubmed/25405956
http://dx.doi.org/10.1021/bi501396v
_version_ 1782349483032444928
author Seo, Jeong-Woo
Ma, Ming
Kwong, Thomas
Ju, Jianhua
Lim, Si-Kyu
Jiang, Hui
Lohman, Jeremy R.
Yang, Chunying
Cleveland, John
Zazopoulos, Emmanuel
Farnet, Chris M.
Shen, Ben
author_facet Seo, Jeong-Woo
Ma, Ming
Kwong, Thomas
Ju, Jianhua
Lim, Si-Kyu
Jiang, Hui
Lohman, Jeremy R.
Yang, Chunying
Cleveland, John
Zazopoulos, Emmanuel
Farnet, Chris M.
Shen, Ben
author_sort Seo, Jeong-Woo
collection PubMed
description [Image: see text] Lactimidomycin (LTM, 1) and iso-migrastatin (iso-MGS, 2) belong to the glutarimide-containing polyketide family of natural products. We previously cloned and characterized the mgs biosynthetic gene cluster from Streptomyces platensis NRRL 18993. The iso-MGS biosynthetic machinery featured an acyltransferase (AT)-less type I polyketide synthase (PKS) and three tailoring enzymes (MgsIJK). We now report cloning and characterization of the ltm biosynthetic gene cluster from Streptomyces amphibiosporus ATCC 53964, which consists of nine genes that encode an AT-less type I PKS (LtmBCDEFGHL) and one tailoring enzyme (LtmK). Inactivation of ltmE or ltmH afforded the mutant strain SB15001 or SB15002, respectively, that abolished the production of 1, as well as the three cometabolites 8,9-dihydro-LTM (14), 8,9-dihydro-8S-hydroxy-LTM (15), and 8,9-dihydro-9R-hydroxy-LTM (13). Inactivation of ltmK yielded the mutant strain SB15003 that abolished the production of 1, 13, and 15 but led to the accumulation of 14. Complementation of the ΔltmK mutation in SB15003 by expressing ltmK in trans restored the production of 1, as well as that of 13 and 15. These results support the model for 1 biosynthesis, featuring an AT-less type I PKS that synthesizes 14 as the nascent polyketide intermediate and a cytochrome P450 desaturase that converts 14 to 1, with 13 and 15 as minor cometabolites. Comparative analysis of the LTM and iso-MGS AT-less type I PKSs revealed several unusual features that deviate from those of the collinear type I PKS model. Exploitation of the tailoring enzymes for 1 and 2 biosynthesis afforded two analogues, 8,9-dihydro-8R-hydroxy-LTM (16) and 8,9-dihydro-8R-methoxy-LTM (17), that provided new insights into the structure–activity relationship of 1 and 2. While 12-membered macrolides, featuring a combination of a hydroxyl group at C-17 and a double bond at C-8 and C-9 as found in 1, exhibit the most potent activity, analogues with a single hydroxyl or methoxy group at C-8 or C-9 retain most of the activity whereas analogues with double substitutions at C-8 and C-9 lose significant activity.
format Online
Article
Text
id pubmed-4270375
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42703752015-11-18 Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues Seo, Jeong-Woo Ma, Ming Kwong, Thomas Ju, Jianhua Lim, Si-Kyu Jiang, Hui Lohman, Jeremy R. Yang, Chunying Cleveland, John Zazopoulos, Emmanuel Farnet, Chris M. Shen, Ben Biochemistry [Image: see text] Lactimidomycin (LTM, 1) and iso-migrastatin (iso-MGS, 2) belong to the glutarimide-containing polyketide family of natural products. We previously cloned and characterized the mgs biosynthetic gene cluster from Streptomyces platensis NRRL 18993. The iso-MGS biosynthetic machinery featured an acyltransferase (AT)-less type I polyketide synthase (PKS) and three tailoring enzymes (MgsIJK). We now report cloning and characterization of the ltm biosynthetic gene cluster from Streptomyces amphibiosporus ATCC 53964, which consists of nine genes that encode an AT-less type I PKS (LtmBCDEFGHL) and one tailoring enzyme (LtmK). Inactivation of ltmE or ltmH afforded the mutant strain SB15001 or SB15002, respectively, that abolished the production of 1, as well as the three cometabolites 8,9-dihydro-LTM (14), 8,9-dihydro-8S-hydroxy-LTM (15), and 8,9-dihydro-9R-hydroxy-LTM (13). Inactivation of ltmK yielded the mutant strain SB15003 that abolished the production of 1, 13, and 15 but led to the accumulation of 14. Complementation of the ΔltmK mutation in SB15003 by expressing ltmK in trans restored the production of 1, as well as that of 13 and 15. These results support the model for 1 biosynthesis, featuring an AT-less type I PKS that synthesizes 14 as the nascent polyketide intermediate and a cytochrome P450 desaturase that converts 14 to 1, with 13 and 15 as minor cometabolites. Comparative analysis of the LTM and iso-MGS AT-less type I PKSs revealed several unusual features that deviate from those of the collinear type I PKS model. Exploitation of the tailoring enzymes for 1 and 2 biosynthesis afforded two analogues, 8,9-dihydro-8R-hydroxy-LTM (16) and 8,9-dihydro-8R-methoxy-LTM (17), that provided new insights into the structure–activity relationship of 1 and 2. While 12-membered macrolides, featuring a combination of a hydroxyl group at C-17 and a double bond at C-8 and C-9 as found in 1, exhibit the most potent activity, analogues with a single hydroxyl or methoxy group at C-8 or C-9 retain most of the activity whereas analogues with double substitutions at C-8 and C-9 lose significant activity. American Chemical Society 2014-11-18 2014-12-16 /pmc/articles/PMC4270375/ /pubmed/25405956 http://dx.doi.org/10.1021/bi501396v Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Seo, Jeong-Woo
Ma, Ming
Kwong, Thomas
Ju, Jianhua
Lim, Si-Kyu
Jiang, Hui
Lohman, Jeremy R.
Yang, Chunying
Cleveland, John
Zazopoulos, Emmanuel
Farnet, Chris M.
Shen, Ben
Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title_full Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title_fullStr Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title_full_unstemmed Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title_short Comparative Characterization of the Lactimidomycin and iso-Migrastatin Biosynthetic Machineries Revealing Unusual Features for Acyltransferase-less Type I Polyketide Synthases and Providing an Opportunity To Engineer New Analogues
title_sort comparative characterization of the lactimidomycin and iso-migrastatin biosynthetic machineries revealing unusual features for acyltransferase-less type i polyketide synthases and providing an opportunity to engineer new analogues
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270375/
https://www.ncbi.nlm.nih.gov/pubmed/25405956
http://dx.doi.org/10.1021/bi501396v
work_keys_str_mv AT seojeongwoo comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT maming comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT kwongthomas comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT jujianhua comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT limsikyu comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT jianghui comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT lohmanjeremyr comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT yangchunying comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT clevelandjohn comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT zazopoulosemmanuel comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT farnetchrism comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues
AT shenben comparativecharacterizationofthelactimidomycinandisomigrastatinbiosyntheticmachineriesrevealingunusualfeaturesforacyltransferaselesstypeipolyketidesynthasesandprovidinganopportunitytoengineernewanalogues